Peter M. Hecht
2011 - Ironwood Pharmaceuticals
In 2011, Peter M. Hecht earned a total compensation of $1.1M as Chief Executive Officer at Ironwood Pharmaceuticals, a 21% increase compared to previous year.
Compensation breakdown
| Option Awards | $1,014,772 |
|---|---|
| Salary | $100,000 |
| Other | $4,440 |
| Total | $1,119,212 |
Hecht received $1M in option awards, accounting for 91% of the total pay in 2011.
Hecht also received $100K in salary and $4.4K in other compensation.
Rankings
In 2011, Peter M. Hecht's compensation ranked 5,256th out of 10,747 executives tracked by ExecPay. In other words, Hecht earned more than 51.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,256 out of 10,747 | 51st |
Division Manufacturing | 1,906 out of 3,960 | 52nd |
Major group Chemicals And Allied Products | 412 out of 1,033 | 60th |
Industry group Drugs | 258 out of 781 | 67th |
Industry Pharmaceutical Preparations | 204 out of 571 | 64th |
Source: SEC filing on April 18, 2014.
Hecht's colleagues
We found three more compensation records of executives who worked with Peter M. Hecht at Ironwood Pharmaceuticals in 2011.
News
Cyclerion Therapeutics COO Cheryl Gault's 2022 pay slips 3% to $645K
April 3, 2023
Cyclerion Therapeutics CSO Andreas Busch's 2021 pay slips 3% to $783K
April 26, 2022
Cyclerion Therapeutics CSO Andreas Busch's 2020 pay falls 75% to $807K
April 28, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019